REN and diabetic kidney disease: Finally, renin–angiotensin system inhibitors (RASi) have a pivotal role in the management of DKD, and some data report a positive effect in preventing fibrosis progression in MASLD as they seem to reduce oxidative stress and block activation of hepatic stellate cells [102].